Morgan Stanley Rezolute, Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Rezolute, Inc. stock. As of the latest transaction made, Morgan Stanley holds 237,153 shares of RZLT stock, worth $1.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

237,153

Previous 156,319 51.71%

Holding current value

$1.47 Million

Previous $453,000 133.33%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$2.47 - $4.46 $199,659 - $360,519	80,834 Added 51.71%	237,153 $1.06 Million
Q1 2025 May 15, 2025	BUY	$2.73 - $5.57 $276,742 - $564,636	101,371 Added 184.49%	156,319 $453,000
Q4 2024 Feb 14, 2025	SELL	$4.08 - $5.96 $98,250 - $143,522	-24,081 Reduced 30.47%	54,948 $262,000
Q3 2024 May 14, 2025	SELL	$4.13 - $5.31 $1.33 Million - $1.71 Million	-321,217 Reduced 80.25%	79,029 $383,000
Q3 2024 Nov 14, 2024	SELL	$4.13 - $5.31 $1.33 Million - $1.71 Million	-321,217 Reduced 80.25%	79,029 $383,000
Q2 2024 May 14, 2025	BUY	$2.29 - $5.79 $790,732 - $2 Million	345,298 Added 628.41%	400,246 $1.72 Million
Q2 2024 Oct 17, 2024	BUY	$2.29 - $5.79 $911,820 - $2.31 Million	398,175 Added 19226.22%	400,246 $1.72 Million
Q2 2024 Aug 14, 2024	BUY	$2.29 - $5.79 $911,820 - $2.31 Million	398,175 Added 19226.22%	400,246 $1.72 Million
Q1 2024 Oct 17, 2024	SELL	$0.95 - $2.55 $378,266 - $1.02 Million	-398,175 Reduced 99.48%	2,071 $5,000
Q4 2023 Aug 16, 2024	SELL	$0.74 - $1.24 $294,649 - $493,737	-398,175 Reduced 99.48%	2,071 $2,000
Q4 2022 Feb 14, 2023	BUY	$1.38 - $2.84 $2,788 - $5,739	2,021 Added 4042.0%	2,071 $4,000
Q3 2022 Nov 14, 2022	BUY	$2.19 - $3.49 $63 - $101	29 Added 138.1%	50 $0
Q4 2021 Feb 14, 2022	SELL	$4.21 - $7.61 $2,109 - $3,812	-501 Reduced 95.98%	21 $0
Q3 2021 Nov 15, 2021	BUY	$7.45 - $13.66 $3,888 - $7,130	522 New	522 $4,000

Others Institutions Holding RZLT

# of Institutions

Shares Held

59.4M

Call Options Held

713K

Put Options Held

19K

View Full List

About Rezolute, Inc.

Ticker RZLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,600
Market Cap $241M
Description
Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...

More about RZLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account